Abstract
A sensitive and rapid ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method was developed to determine methadone, EDDP, fluoxetine, norfluoxetine, venlafaxine and O-desmethylvenlafaxine in rat plasma using diazepam as the internal standard (IS). Sample preparation was accomplished through a simple one-step protein precipitation with 200 µL acetonitrile added to 100 µL rat plasma. The analytes were separated on an Acquity UPLC BEH C18 column (2.1 × 50 mm, 1.7 µm) and the mobile phase was acetonitrile and 0.1 % formic acid in water in gradient elution at a flow rate of 0.40 mL min−1. The detection was performed on a triple quadrupole tandem mass spectrometer equipped with positive electrospray ionization (ESI) by multiple reactions monitoring (MRM) of the transitions. The linearity of this method was found to be within the concentration range of 0.5–250.0 ng mL−1 for methadone, EDDP, fluoxetine and norfluoxetine and 0.4–200.0 ng mL−1 for venlafaxine and O-desmethylvenlafaxine, respectively. The limit of quantification (LOQ) was 0.5 ng mL−1 for methadone, EDDP, fluoxetine and norfluoxetine and 0.4 ng mL−1 for venlafaxine and O-desmethylvenlafaxine, respectively. A time period of 3 min was needed for an analytical run. The method described above was successfully applied to the subsequent pharmacokinetic study.
Similar content being viewed by others
References
Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P (2014) Am J Epidemiol 180:673–686. doi:10.1093/aje/kwu190
Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, Inturrisi C, Knight JR, Otis-Green S, Marcus SM, Mehta D, Meyer MC, Portenoy R, Savage S, Strain E, Walsh S, Zeltzer L (2014) J Pain 15:321–337. doi:10.1016/j.jpain.2014.01.494
Wang JS, DeVane CL (2003) Drug Metab Dispos 31:742–747
Lu WJ, Bies R, Kamden LK, Desta Z, Flockhart DA (2010) Drug Metab Dispos 38:1308–1313. doi:10.1124/dmd.110.032474
Magalhaes P, Alves G, Llerena A, Falcao A (2014) Drug Metabol Drug Interact 29:129–141. doi:10.1515/dmdi-2013-0053
Murrell MD, Cruz DA, Javors MA, Thompson PM (2014) J Forensic Sci 59:683–689. doi:10.1111/1556-4029.12393
Margolis JM, O’Donnell JP, Mankowski DC, Ekins S, Obach RS (2000) Drug Metab Dispos 28:1187–1191
Emery PC, Wilson KG, Kowal J (2014) Major depressive disorder and sleep disturbance in patients with chronic pain. Pain Res Manag 19(1):35–41
Hirsh AT, Hollingshead NA, Bair MJ, Matthias MS, Kroenke K (2014) Clin J Pain 30:766–774. doi:10.1097/ajp.0000000000000035
Martinez TT, Martinez DN (2008) Proc West Pharmacol Soc 51:42–44
Lee J, Franz L, Goforth HW (2009) Psychosomatics 50:638–639. doi:10.1176/appi.psy.50.6.638
Bonde SL, Bhadane RP, Gaikwad A, Gavali SR, Katale DU, Narendiran AS (2014) J Pharm Biomed Anal 90:64–71. doi:10.1016/j.jpba.2013.10.033
Houbart V, Servais AC, Charlier TD, Pawluski JL, Abts F, Fillet M (2012) Electrophoresis 33:3370–3379. doi:10.1002/elps.201200168
Berm EJ, Brummel-Mulder E, Paardekooper J, Hak E, Wilffert B, Maring JG (2014) Anal Bioanal Chem 406:2349–2353. doi:10.1007/s00216-014-7619-9
Odoardi S, Anzillotti L, Strano-Rossi S (2014) Forensic Sci Int 243:61–67. doi:10.1016/j.forsciint.2014.04.015
Koster RA, Alffenaar JW, Greijdanus B, VanDernagel JE, Uges DR (2014) Ther Drug Monit 36:234–243. doi:10.1097/FTD.0b013e3182a377e8
Tang MH, Ching CK, Lee CY, Lam YH, Mak TW (2014) J Chromatogr B Analyt Technol Biomed Life Sci 969:272–284. doi:10.1016/j.jchromb.2014.08.033
Imbert L, Dulaurent S, Mercerolle M, Morichon J, Lachatre G, Gaulier JM (2014) Forensic Sci Int 234:132–138. doi:10.1016/j.forsciint.2013.11.004
Scheidweiler KB, Huestis MA (2014) J Chromatogr A 1327:105–117. doi:10.1016/j.chroma.2013.12.067
Kiss B, Bogdan C, Pop A, Loghin F (2012) Talanta 99:649–659. doi:10.1016/j.talanta.2012.06.070
de Castro A, Concheiro M, Quintela O, Cruz A, Lopez-Rivadulla M (2008) J Pharm Biomed Anal 48:183–193. doi:10.1016/j.jpba.2008.05.024
Patel BN, Sharma N, Sanyal M, Shrivastav PS (2008) J Pharm Biomed Anal 47:603–611. doi:10.1016/j.jpba.2008.02.015
Sutherland FC, Badenhorst D, de Jager AD, Scanes T, Hundt HK, Swart KJ, Hundt AF (2001) J Chromatogr A 914:45–51
Bhatt J, Jangid A, Venkatesh G, Subbaiah G, Singh S (2005) J Chromatogr B, Anal Technol Biomed Life Sci 829:75–81. doi:10.1016/j.jchromb.2005.09.034
Acknowledgments
This work was supported by the Ministry of Health of the People’s Republic of China (201302008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Additional information
P.-P. Pan and S.-H. Wang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Pan, PP., Wang, SH., Wang, J. et al. Simultaneous Determination of Methadone, Fluoxetine, Venlafaxine and Their Metabolites in Rat Plasma by UPLC–MS/MS for Drug Interaction Study. Chromatographia 79, 601–608 (2016). https://doi.org/10.1007/s10337-016-3062-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-016-3062-8